Rifamycin resistance in mycobacteria

Research in Microbiology

Volumn 147, Issue 1-2, 1996, Pages 48-52

  Cole, S T ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RIFABUTIN; RIFAMPICIN; RIFAMYCIN; RNA POLYMERASE;

CONFERENCE PAPER; DRUG EFFICACY; GENE MUTATION; HUMAN; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL;

EID: 0029914382     PISSN: 09232508     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2508(96)80203-8     Document Type: Conference Paper

References (43)

1. Bodmer, T., Zürcher, G., Imboden, P. & Telenti, A. (1995), Mutation position and type of substitution in the β-subunit of the RNA polymerase influence invitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother., 35, 345-348.
2. Carter, P.E., Abadia, F.J.R., Yakubu, D.E. & Pennington, T.H. (1994), Molecular characterization of rifampin-resistant Neisseria meningitidis. Antimicrob. Agents Chemother., 38, 1256-1261.
3. Chamberlin, M.J. (1976), RNA polymerase an overview, in "RNA polymerase" (R. Losick & M. Chamberlin) (pp. 17-67). Cold Spring Harbor Laboratory, New York.
4. Cole, S.T. (1994), Mycobacterium tuberculosis: drug resistance mechanims. Trends Microbiol., 2, 411-415.
5. Collins, D.M., Kwakami, R.P., de Lisle, G.W., Pascopella, L., Bloom, B.R. & Jacobs, J. W.R. (1995), Mutation of the principal σ factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA, 92, 8036-8040.
6. Dabbs, E.R., Yazawa, K., Mikami, Y., Miyaji, M., Morisaki, N., Iwasaki, S. & Furihata, K. (1995), Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation. Antimicrob. Agents Chemother., 39, 1007-1009.
7. Della Bruna, C., Schioppacassi, G., Ungheri, D., Jabes, D., Morvillo, E. & Sanfilippo, A. (1983), LM427, a new spiropiperidyl rifamycin: in vitro and in vivo studies. J. Antibiot., 34, 1502-1506.
8. Dickinson, J.M. & Mitchison, D.A. (1987), In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria. Tubercle, 68, 177-182.
9. Donnabella, V., Martiniuk, F., Kinney, D., Bacerdo, M., Bonk, S., Hanna, B. & Rom, W. (1994), Isolation of the gene for the beta subunit of RNA polymerase from rifampicin-resistant Mycobacterium tuberculosis and identification of new mutations. Am. J. Respir. Cell Mol. Biol., 11, 639-43.
10. Doukhan, L., Predich, L., Nair, G., Cole, S.T., Smith, D.R. & Smith, I. (1995), Genomic organization of the mycobacterial sigma gene cluster. Gene, 165, 67-70.
11. Guerrero, C., Stockman, L., Marchesi, F., Bodmer, T., Roberts, G. & Telenti, A. (1994), Evaluation of the rpoB gene in rifampicin-susceptible and resistant Mycobacterium avium and M. intracellulare. J. Antimicrob. Chemother., 33, 661-663.
12. Harshey, R.M. & Ramakrishnan, T. (1976), Purification and properties of DNA-dependent RNA polymerase from Mycobacterium tuberculosis H37Rv. Biochem. Biophys. Acta, 432, 49-59.
13. Heifets, L.B. (1991), Drug susceptibility in the chemotherapy of mycobacterial infections. CRC Press, Boca Raton, 123-146.
14. Heym, B., Honoré, N., Truffot-Pernot, C., Banerjee, A., Schurra, C., Jacobs, W.R., Jr., van Embden, J.D.A., Grosset, J.H. & Cole, S.T. (1994), The implications of multidrug resistance for the future of short course chemotherapy of tuberculosis: a molecular study. Lancet, 344, 293-298.
15. Honoré, N., Bergh, S., Chanteau, S., Doucet-Populaire, F., Eiglmeier, K., Gamier, T., Georges, C., Launois, P., Limpaiboon, P., Newton, S., Nyang, K., del Portillo, P., Ramesh, G.K., Reddy, T., Riedel, J.P., Sittisombut, N., Wu-Hunter, S. & Cole, S.T. (1993), Nucleotide sequence of the first cosmid from the Mycobacterium leprae genome project: structure and function of the Rif-Str regions. Mol. Microbiol., 7, 207-214.
16. Honoré, N. & Cole, S.T. (1993), Molecular basis of rifampin-resistance in Mycobacterium leprae. Antimicrob. Agents Chemother., 37, 414-418.
17. Honoré, N., Perani, E., Telenti, A., Grosset, J. & Cole, S.T. (1994), A simple and rapid technique for the detection of rifampin resistance in Mycobacterium leprae. Int. J. Lepr., 61, 600-604.
18. Hui, J., Gordon, N. & Kajioka, R. (1977), Permeability barriers to rifampin in mycobacteria. Antimicrob. Agents Chemother., 11, 773-779.
19. Jin, D.J. & Gross, C.A. (1988), Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to Rifampicin resistance. J. Mol. Biol., 202, 45-58.
20. Jin, D.J. & Gross, C.A. (1989), Characterization of the pleiotropic phenotypes of Rifampin-resistant rpoB mutants of Escherichia coli. J. Bacteriol., 171, 5229-5231.
21. Kapur, V., Hamrick, M.R., Li, L.-L., Plikaytis, B.B., Shinnick, T.M., Telenti, A., Jacobs, W.R., Banerjee, A., Cole, S.T., Yam, W.C., Clarridge, I.E., Kreiswirth, B.N. & Musser, J.M. (1995), Application of automated DNA sequencing strategies to problems of Mycobacterium diagnostics : speciation by characterization of polymorphisms in the gene (hsp65) encoding a 65-kilodalton heat shock protein, and a rapid and unambiguous identification of mutations associated with antibiotic resistance in Mycobacterium tuberculosis. Arch. Pathol. Lab. Med., 119, 131-8.
22. Kapur, V., Li, L.-L., Iordanescu, S., Hamrick, M.R., Wanger, A., Kreiswirth, B.N. & Musser, J.M. (1994), Characterization by automated sequencing of mutations in the gene (rpoB) encoding the RNA polymerase β subunit in rifampicin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol., 32, 1095-1098.
23. Levin, M.E. & Hatfull, G.F. (1993), Mycobacterium smegmatis RNA polymerase: DNA supercoiling, action of rifampicin and mechanism of rifampicin resistance. Mol. Microbiol., 8, 277-285.
24. Lonetto, M., Gribskov, M. & Gross, C.A. (1992), The σ70 family: sequence conservation and evolutionary relationships. J. Bacteriol., 174, 3843-3849.
25. Martin, C., Ranes, M. & Gicquel, B. (1990), Plasmids, antibiotic resistance, and mobile genetic elements in mycobacteria, in "Molecular Biology of the Mycobacteria" (J. McFadden) (pp. 121-138). Surrey University Press, Guildford.
26. Miller, L.P., Crawford, J.T. & Shinnick, T.M. (1994), The rpoB gene of Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 38, 805-811.
27. Morris, S., Bai, G., Suffys, P., Portillo-Gomez, L., Fairchok, M. & Rouse, D. (1995), Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis., 171, 954-60.
28. Nightingale, S.D., Cameron, D.W., Gordin, P.M., Sullam, P.M., Cohn, D.L., Chaisson, R.E., Eron, L.J., Sparti, P.D., Bihari, B., Kaufman, D.L., Stern, J.J., Pearce, D.D., Weinberg, W.G., LaMarca, A. & Siegal, P.P. (1993), Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N. Engl. J. Med., 329, 828-833.
29. Ohno, H., Koga, H., Kohno, S., Higashiyama, Y., Miyazaki, Y., Ogawa, K., Yanagihra, K., Yamamoto, Y., Noda, T. & Miyamoto, J. (1994), Evaluation for rapid detection of rifampicin-resistant Mycobacterium tuberculosis by polymerase chain reaction-single strand conformation polymorphism. Kekkaku, 69, 773-778.
30. Predich, M., Doukhan, L., Nair, G. & Smith, I. (1995), Characterization of RNA polymerase and two sigma factor genes from Mycobacterium smegmatis. Mol. Microbiol., 15, 355-366.
31. Reichmann, L.B., McDonald, R.J. & Mangura, B.T. (1994), Rifabutin prophylaxis against Mycobacterium avium complex infection. N. Engl. J. Med., 330, 437-438.
32. Severinov, K., Kashlev, M., Severinova, E., Bass, I., McWilliams, K., Kutter, E., Nikiforov, V., Snyder, L. & Goldfarb, A. (1994a), A non-essential domain of Escherichia coli RNA polymerase required for the action of the termination factor Alc. J. Biol. Chem., 269, 14254-9.
33. Severinov, K., Soushko, M., Goldfarb, A. & Nikiforov, V. (1993), Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase. J. Biol. Chem., 268, 14820-5.
34. Severinov, K., Soushko, M., Goldfarb, A. & Nikiforov, V. (1994b), RifR mutations in the beginning of the Escherichia coli rpoB gene. Mol. Gen. Genet., 244, 120-126.
35. Suzuki, Y., Katsukawa, C., Inoue, K., Yion, Y., Tasaka, H., Ueba, N. & Makino, M. (1995), Mutations in rpoB gene of rifampicin resistant clinical isolates of Mycobacterium tuberculosis in Japan. Kaanssenshogaku Zasshi, 69, 413-419.
36. Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M.J., Matter, L., Schopfer, K. & Bodmer, T. (1993a), Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647-650.
37. Telenti, A., Imboden, P., Marchesi, F., Schmidheini, T. & Bodmer, T. (1993b), Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob. Agents Chemother., 37, 2054-2058.
38. Tsukamura, M. (1972), The pattern of resistance development to rifampicin in Mycobacterium tuberculosis. Tubercle, 53, 111-117.
39. Weltman, A.C., Righi, S.P., DiFernando, J., G.T., Jovell, R.J. & Driscoll, J.R. (1995), Rifampicin-resistant Mycobacterium tuberculosis. Lancet, 345, 1513.
40. Williams, D.L., Waguespack, C., Eisenach, K., Crawford, J.T., Portaels, F., Salfinger, M., Nolan, C.M., Abe, C., Sticht-Groh, V. & Gillis, T.P. (1994), Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother., 38, 2380-2386.
41. Winder, F.G. (1982), Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of mycobacteria, in "The biology of the mycobacteria" (C. Ratledge & D. Stanford, Vol. 1) (pp. 353-438). Academic Press, New York.
42. Woodley, C.L. & Kilburn, J.O. (1982), In vitro susceptibility of Mycobacterium avium and Mycobacterium tuberculosis strains to a spiropiperidyl rifamycin. Am. Rev. Respir. Dis., 126, 586-587.
43. Yamori, S. & Tsukamura, M. (1991), Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfadimethoxine in the Mycobacterium avium-intra-cellulare complex. Microbiol. Immunol., 35, 921-926.